Prognostic significance of autophagy-related proteins expression in resected human gastric adenocarcinoma

Abstract

Gastric adenocarcinoma (GC) is one of the most common malignancies in the world and one of the most frequent causes of cancer-related death. Autophagy is a highly regulated catabolic pathway responsible for the degradation of long-lived proteins and damaged intracellular organelles. However, the mechanism and guiding significance of autophagy in the development and progression of GC have remained to be elucidated. This study aimed to explore the clinicopathological significances and prognostic values of autophagy-related proteins AMBRA1 and Beclin-1 in GC. Quantum dots based immunofluorescence histochemistry (QDs-IHC) was performed to observe the expression of AMBRA1 and Beclin-1 proteins in the tissue microarrays including 163 specimens of GC and 20 noncancerous gastric tissues. Simultaneously, AMBRA1 and Beclin-1 proteins were detected by Western blotting in the 10 fresh GC and corresponding normal gastric tissues. The results showed that the expression levels of both AMBRA1 and Beclin-1 proteins were higher in GC tissues than in noncancerous gastric tissues by QDs-IHC and Western blotting (P<0.05). High AMBRA1 expression was detected in 90 of 163 (55.2%) GCs and high Beclin-1 expression was detected in 83 of 163 (50.9%) GCs. High AMBRA1 expression was closely related to depth of invasion, and lymph nodes metastasis (P<0.05). High expression of Beclin-1 protein was correlated with tumor grade (P<0.05). Positive correlation was observed between AMBRA1 and Beclin-1. Survival analysis indicated the high expression of AMBRA1 and Beclin- 1 was an independent factor in predicting poor overall survival (OS) of GC patients. These findings suggest the high expression of AMBRA1 and Beclin-1 proteins is significantly correlated with GC progression. High AMBRA1 and Beclin-1 expression heralds worse outcome of GC patients, suggesting a novel candidate prognostic marker and a therapeutic target for GC.

Keywords

gastric carcinoma / autophagy / AMBRA1 / Beclin-1 / prognosis

References

[1] TorreLA, BrayF, SiegelRL, et al. . Global cancer statistics, 2012. CA Cancer J Clin, 2015, 65(2): 87-108 PMID: 25651787

[2] DuraesC, AlmeidaGM, SerucaR, et al. . Biomarkers for gastric cancer: prognostic, predictive or targets of therapy?. Virchows Arch, 2014, 464(3): 367-378 PMID: 24487788

[3] GroupG, ObaK, PaolettiX, et al. . Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis. Eur J Cancer, 2013, 49(7): 1565-1577

[4] WhiteE, MehnertJM, ChanCS. Autophagy, metabolism, and cancer. Clin Cancer Res, 2015, 21(22): 5037-5046 PMID: 26567363 PMCID: 4646728

[5] WhiteE. The role for autophagy in cancer. J Clin Invest, 2015, 125(1): 42-46 PMID: 25654549 PMCID: 4382247

[6] LiangCY, JungJU. Autophagy genes as tumor suppressors. Curr Opin Cell Biol, 2010, 22(2): 226-233 PMID: 19945837

[7] WhiteE D, PaolaRS. The double-edged sword of autophagy modulation in cancer. Clin Cancer Res, 2009, 15(17): 5308-5316 PMID: 19706824 PMCID: 2737083

[8] SunWL. Ambra1 in autophagy and apoptosis: implications for cell survival and chemotherapy resistance. Oncol Lett, 2016, 12(1): 367-374 PMID: 27347152 PMCID: 4906955

[9] FimiaGM, StoykovaA, RomagnoliA, et al. . Ambra1 regulates autophagy and development of the nervous system. Nature, 2007, 447(7148): 1121-1125 PMID: 17589504

[10] FimiaGM, CorazzariM, AntonioliM, et al. . Ambra1 at the crossroad between autophagy and cell death. Oncogene, 2013, 32(28): 3311-3318 PMID: 23069654

[11] GuW, WanDW, QianQY, et al. . Ambra1 is an essential regulator of autophagy and apoptosis in SW620 cells: Pro-survival role of Ambra1. Plos One, 2014, 9(2): e90151 PMID: 24587252 PMCID: 3936000

[12] TotonE, LisiakN, SawickaP, et al. . Beclin-1 and its role as a target for anticancer therapy. J Physiol Pharmacol, 2014, 65(4): 459-467 PMID: 25179078

[13] FuLL, ChengY, LiuB. Beclin-1: autophagic regulator and therapeutic target in cancer. Int J Biochem Cell Biol, 2013, 45(5): 921-924 PMID: 23420005

[14] KononenJ, BubendorfL, KallionimeniA, et al. . Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med, 1998, 4(7): 844-847 PMID: 9662379

[15] LiM, ChenH, DiaoL, et al. . Caveolin-1 and VEGF-C promote lymph node metastasis in the absence of intratumoral lymphangiogenesis in non-small cell lung cancer. Tumori, 2010, 96(5): 734-743 PMID: 21302621

[16] ChenH, XueJ, ZhangY, et al. . Comparison of quantum dots immunofluorescence histochemistry and conventional immunohistochemistry for the detection of caveolin-1 and PCNA in the lung cancer tissue microarray. J Mol Histol, 2009, 40(4): 261-268 PMID: 19908148

[17] ZhaoX, HeY, GaoJ, et al. . Caveolin-1 expression level in cancer associated fibroblasts predicts outcome in gastric cancer. PLoS One, 2013, 8(3): e59102 PMID: 23527097 PMCID: 3602462

[18] LiJ, YangB, ZhouQ, et al. . Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelial-mesenchymal transition. Carcinogenesis, 2013, 34(6): 1343-1351 PMID: 23430956

[19] KoukourakisMI, GiatromanolakiA, SivridisE, et al. . Beclin 1 over-and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia. Br J Cancer, 2010, 103(8): 1209-1214 PMID: 20842118 PMCID: 2967071

[20] QianHR, YangY. Functional role of autophagy in gastric cancer. Oncotarget, 2016, 7(14): 17641-17651 PMID: 26910278 PMCID: 4951239

[21] KoYH, ChoYS, WonHS, et al. . Prognostic significance of autophagy-related protein expression in resected pancreatic ductal adenocarcinoma. Pancreas, 2013, 42(5): 829-835 PMID: 23429496

[22] NittaT, SatoY, RenXS, et al. . Autophagy may promote carcinoma cell invasion and correlate with poor prognosis in cholangiocarcinoma. Int J Clin Exp Med, 2014, 7(8): 4913-4921

[23] FalascaL, TorinoF, MarconiM, et al. . AMBRA1 and SQSTM1 expression pattern in prostate cancer. Apoptosis, 2015, 20(12): 1577-1586 PMID: 26423274 PMCID: 4602066

[24] CianfanelliV, CecconiF. AMBRA1: When autophagy meets cell proliferation. Autophagy, 2015, 11(9): 1705-1707 PMID: 26101901 PMCID: 4590640

[25] YuM, GouWF, ZhaoS, et al. . Beclin 1 expression is an independent prognostic factor for gastric carcinomas. Tumour Biol, 2013, 34(2): 1071-1083 PMID: 23334926

[26] AhnCH, JeongEG, LeeJW, et al. . Expression of beclin-1, an autophagy-related protein, in gastric and colorectal cancers. APMIS, 2007, 115(12): 1344-1349 PMID: 18184403

[27] FeiBY, JiFJ, ChenXB, et al. . Expression and clinical significance of Beclin-1 in gastric cancer tissues of various clinical stages. Oncol Lett, 2016, 11(3): 2271-2277 PMID: 26998161 PMCID: 4774614

[28] YuM, GouWF, ZhaoS, et al. . Beclin 1 expression is an independent prognostic factor for gastric carcinomas. Tumour Biol, 2013, 34(2): 1071-1083 PMID: 23334926

[29] WonKY, KimGY, LimSJ, et al. . Autophagy is related to the hedgehog signaling pathway in human gastric adenocarcinoma: prognostic significance of Beclin-1 and Gli2 expression in human gastric adenocarcinoma. Pathol Res Pract, 2015, 211(4): 308-315 PMID: 25512258

[30] ChenYB, HouJH, FengXY, et al. . Decreased expression of Beclin 1 correlates with a metastatic phenotypic feature and adverse prognosis of gastric carcinomas. J Surg Oncol, 2012, 105(6): 542-547 PMID: 22095667

[31] HeY, ZhaoX, SubahanNR, et al. . The prognostic value of autophagy-related markers beclin-1 and microtubule-associated protein light chain 3B in cancers: a systematic review and meta-analysis. Tumour Biol, 2014, 35(8): 7317-7326 PMID: 24838948

[32] WanXB, FanXJ, ChenMY, et al. . Elevated Beclin 1 expression is correlated with HIF-1alpha in predicting poor prognosis of nasopharyngeal carcinoma. Autophagy, 2010, 6(3): 395-404 PMID: 20150769